IBDEI34I ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49885,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
 ;;^UTILITY(U,$J,358.3,49885,1,4,0)
 ;;=4^I82.409
 ;;^UTILITY(U,$J,358.3,49885,2)
 ;;=^5133625
 ;;^UTILITY(U,$J,358.3,49886,0)
 ;;=I82.509^^193^2485^27
 ;;^UTILITY(U,$J,358.3,49886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49886,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
 ;;^UTILITY(U,$J,358.3,49886,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,49886,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,49887,0)
 ;;=E78.1^^193^2486^23
 ;;^UTILITY(U,$J,358.3,49887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49887,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,49887,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,49887,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,49888,0)
 ;;=E78.2^^193^2486^21
 ;;^UTILITY(U,$J,358.3,49888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49888,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,49888,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,49888,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,49889,0)
 ;;=I10.^^193^2486^9
 ;;^UTILITY(U,$J,358.3,49889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49889,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,49889,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,49889,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,49890,0)
 ;;=I11.9^^193^2486^19
 ;;^UTILITY(U,$J,358.3,49890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49890,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,49890,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,49890,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,49891,0)
 ;;=I11.0^^193^2486^18
 ;;^UTILITY(U,$J,358.3,49891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49891,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,49891,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,49891,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,49892,0)
 ;;=I12.0^^193^2486^15
 ;;^UTILITY(U,$J,358.3,49892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49892,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,49892,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,49892,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,49893,0)
 ;;=I13.10^^193^2486^13
 ;;^UTILITY(U,$J,358.3,49893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49893,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,49893,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,49893,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,49894,0)
 ;;=I13.0^^193^2486^11
 ;;^UTILITY(U,$J,358.3,49894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49894,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,49894,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,49894,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,49895,0)
 ;;=I13.11^^193^2486^14
 ;;^UTILITY(U,$J,358.3,49895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49895,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,49895,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,49895,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,49896,0)
 ;;=I13.2^^193^2486^12
 ;;^UTILITY(U,$J,358.3,49896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49896,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,49896,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,49896,2)
 ;;=^5007070
